252 related articles for article (PubMed ID: 25591627)
21. Decision making and cancer.
Reyna VF; Nelson WL; Han PK; Pignone MP
Am Psychol; 2015; 70(2):105-18. PubMed ID: 25730718
[TBL] [Abstract][Full Text] [Related]
22. Reflections on the opportunities and challenges of applying experience-based co-design (EBCD) to phase 1 clinical trials in oncology.
Graber N; Canova N; Bryant-Lukosius D; Robert G; Navarro-Rodrigo B; Trueb L; Coukos G; Eicher M; Corbière T; Colomer-Lahiguera S
Health Expect; 2024 Aug; 27(4):e14068. PubMed ID: 38937953
[TBL] [Abstract][Full Text] [Related]
23. Patient participation: current knowledge and applicability to patient safety.
Longtin Y; Sax H; Leape LL; Sheridan SE; Donaldson L; Pittet D
Mayo Clin Proc; 2010 Jan; 85(1):53-62. PubMed ID: 20042562
[TBL] [Abstract][Full Text] [Related]
24. Incorporating lesion-to-lesion heterogeneity into early oncology decision making.
Kumar R; Qi T; Cao Y; Topp B
Front Immunol; 2023; 14():1173546. PubMed ID: 37350966
[TBL] [Abstract][Full Text] [Related]
25. Incorporating clinical trial data into daily cancer care.
Pelusi J
J Adv Pract Oncol; 2012 Nov; 3(6):378-84. PubMed ID: 25031968
[TBL] [Abstract][Full Text] [Related]
26. Clinical trials in advanced stage lung cancer: a survey of patients' opinion about their treatment.
Zaric B; Perin B; Ilic A; Kopitovic I; Matijasevic J; Andrijevic L; Secen N; Stanic J; Bijelovic M; Kosjerina Z; Antonic M
Multidiscip Respir Med; 2011 Feb; 6(1):20-7. PubMed ID: 22958587
[TBL] [Abstract][Full Text] [Related]
27. Engaging Our Communities in Active Participation in Clinical Trials: It's a Matter of Trust.
Maron JL
Clin Ther; 2024 May; 46(5):381. PubMed ID: 38796337
[No Abstract] [Full Text] [Related]
28. Bringing a humanistic approach to cancer clinical trials.
Arai RJ; Longo ES; Sponton MH; Del Pilar Estevez Diz M
Ecancermedicalscience; 2017; 11():738. PubMed ID: 28596804
[TBL] [Abstract][Full Text] [Related]
29. Facilitating lifestyle changes to manage menopausal symptoms in women with breast cancer: a randomized controlled pilot trial of The Pink Women's Wellness Program.
Anderson DJ; Seib C; McCarthy AL; Yates P; Porter-Steele J; McGuire A; Young L
Menopause; 2015 Sep; 22(9):937-45. PubMed ID: 25608273
[TBL] [Abstract][Full Text] [Related]
30. Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial.
Basaria S; Travison TG; Alford D; Knapp PE; Teeter K; Cahalan C; Eder R; Lakshman K; Bachman E; Mensing G; Martel MO; Le D; Stroh H; Bhasin S; Wasan AD; Edwards RR
Pain; 2015 Feb; 156(2):280-288. PubMed ID: 25599449
[TBL] [Abstract][Full Text] [Related]
31. Overcoming Barriers to Clinical Trial Enrollment.
Nipp RD; Hong K; Paskett ED
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():105-114. PubMed ID: 31099636
[TBL] [Abstract][Full Text] [Related]
32. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.
Unger JM; Vaidya R; Hershman DL; Minasian LM; Fleury ME
J Natl Cancer Inst; 2019 Mar; 111(3):245-255. PubMed ID: 30856272
[TBL] [Abstract][Full Text] [Related]
33. The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.
Unger JM; Cook E; Tai E; Bleyer A
Am Soc Clin Oncol Educ Book; 2016; 35():185-98. PubMed ID: 27249699
[TBL] [Abstract][Full Text] [Related]
34. A Review of Barriers to Minorities' Participation in Cancer Clinical Trials: Implications for Future Cancer Research.
Salman A; Nguyen C; Lee YH; Cooksey-James T
J Immigr Minor Health; 2016 Apr; 18(2):447-53. PubMed ID: 25822567
[TBL] [Abstract][Full Text] [Related]
35. Cancer patients' perceptions of factors influencing their decisions on participation in clinical drug trials: A qualitative meta-synthesis.
Nielsen ZE; Berthelsen CB
J Clin Nurs; 2019 Jul; 28(13-14):2443-2461. PubMed ID: 30673153
[TBL] [Abstract][Full Text] [Related]
36. Improving Oncology Clinical Trial Participation and Experience.
Zaharoff B; Cipra S
Trends Cancer; 2018 Dec; 4(12):793-796. PubMed ID: 30470299
[TBL] [Abstract][Full Text] [Related]
37. "Ultimately, mom has the call": Viewing clinical trial decision making among patients with ovarian cancer through the lens of relational autonomy.
Asiedu GB; Ridgeway JL; Carroll K; Jatoi A; Radecki Breitkopf C
Health Expect; 2018 Dec; 21(6):981-989. PubMed ID: 29655265
[TBL] [Abstract][Full Text] [Related]
38. Deciding to Enrol in a Cancer Trial: A Systematic Review of Qualitative Studies.
Viljoen B; Chambers SK; Dunn J; Ralph N; March S
J Multidiscip Healthc; 2020; 13():1257-1281. PubMed ID: 33149597
[TBL] [Abstract][Full Text] [Related]
39. A Model of Cancer Clinical Trial Decision-making Informed by African-American Cancer Patients.
Wenzel JA; Mbah O; Xu J; Moscou-Jackson G; Saleem H; Sakyi K; Ford JG
J Racial Ethn Health Disparities; 2015 Jun; 2(2):192-9. PubMed ID: 25960945
[TBL] [Abstract][Full Text] [Related]
40. Digital health interventions for all? Examining inclusivity across all stages of the digital health intervention research process.
Krukowski RA; Ross KM; Western MJ; Cooper R; Busse H; Forbes C; Kuntsche E; Allmeta A; Silva AM; John-Akinola YO; König LM
Trials; 2024 Jan; 25(1):98. PubMed ID: 38291539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]